CIPLA
|
The Current P/S Ratio of CIPLA is 4.44.
Share Price | ₹1,483.0 | Mar 27,2025 |
Market Cap | ₹119,767.1 Cr | |
Sales-TTM | ₹26,981.2 Cr | TTM-Consolidated Results |
Price/Sales | 4.44x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of CIPLA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹119,767.1 Cr] as on Mar 27,2025
(/) Sales [ ₹26,981.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.44x ]
Thus, for CIPLA , the investors are currently willing to pay '4.44 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of CIPLA !
The chart below summarizes the trend in P/S Ratio of CIPLA over the last five years.
Historical PS (Price/Sales) ratio chart of CIPLA
PS Ratio Performance Analysis for CIPLA
- CIPLA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.41x.
- CIPLA 's operated at median p/e ratio of 3.43x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CIPLA 's p/e ratio peaked in Mar2024 at 4.68x.
- CIPLA 's p/e ratio hit its five-year low in Mar2020 of 1.99x.
How does CIPLA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
CIPLA | 26,981.2 | 4.44 | 119,767.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 8.05 | 415,373.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 17.12 | 155,437.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.66 | 109,188.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.11 | 96,992.9 |
MANKIND PHARMA LTD | 11,641.0 | 8.73 | 101,622.0 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.03 | 89,660.5 |
LUPIN LTD | 22,001.6 | 4.19 | 92,189.6 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.19 | 67,738.9 |
ABBOTT INDIA LTD | 6,243.2 | 10.41 | 64,987.3 |
ALKEM LABORATORIES LTD | 12,756.6 | 4.65 | 59,324.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CIPLA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.19x |
Max industry PS | 17.12x |
Median industry PS | 4.65x |
Average industry PS | 6.96x |
You may also like the below Video Courses